Market Overview

Roth Capital Downgraded RTI Biologics, Inc. to Neutral, Raised PT to $5.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for RTIX

DateFirmActionFromTo
Oct 2014Canaccord GenuityMaintainsBuy
Sep 2014JMP SecuritiesMaintainsMarket Outperform
Apr 2014Canaccord GenuityUpgradesHoldBuy

View More Analyst Ratings for RTIX
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (RTIX)

Around the Web, We're Loving...

Get Benzinga's Newsletters